Ayala Pharmaceuticals, Inc. (ADXS)

Ayala Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	4.88	4.88	2.41
Cash & Short-Term Investments	4.88	4.88	2.41
Cash Growth	-	102.74%	-
Receivables	-	-	0.23
Prepaid Expenses	2.14	2.14	0.43
Other Current Assets	0.5	0.5	0.12
Total Current Assets	7.53	7.53	3.19
Property, Plant & Equipment	0.64	0.64	2.42
Goodwill	4.5	4.5	-
Other Intangible Assets	3.9	3.9	-
Long-Term Deferred Charges	-	-	1.95
Other Long-Term Assets	0.01	0.01	0.21
Total Assets	16.58	16.58	7.77
Accounts Payable	6.08	6.08	4.08
Accrued Expenses	6.34	6.34	1.7
Current Portion of Leases	0.17	0.17	0.42
Other Current Liabilities	12.44	12.44	-
Total Current Liabilities	25.02	25.02	6.2
Long-Term Debt	8.14	8.14	-
Long-Term Leases	0.01	0.01	1.33
Other Long-Term Liabilities	7.83	7.83	1.34
Total Liabilities	41	41	8.87
Common Stock	0.01	0.01	0
Additional Paid-In Capital	172.8	172.8	148.05
Retained Earnings	-197.23	-197.23	-149.15
Shareholders' Equity	-24.42	-24.42	-1.1
Total Liabilities & Equity	16.58	16.58	7.77
Total Debt	8.32	8.32	1.75
Net Cash (Debt)	-3.43	-3.43	0.66
Net Cash Per Share	-0.57	-0.57	0.23
Filing Date Shares Outstanding	42.63	42.63	2.9
Total Common Shares Outstanding	11.9	11.9	2.9
Working Capital	-17.49	-17.49	-3.01
Book Value Per Share	-2.05	-2.05	-0.38
Tangible Book Value	-32.82	-32.82	-1.1
Tangible Book Value Per Share	-2.76	-2.76	-0.38
Machinery	0.25	0.25	0.52
Leasehold Improvements	1.11	1.11	1.11

Source: S&P Capital IQ. Standard template. Financial Sources.